“Antidepressant drugs act by directly binding to TRKB neurotrophin receptors”

Casarotto et al. Cell (2021)

Group Description: The recent development of novel, fast acting, and durable antidepressant treatments such as Ketamine, Brexanolone, and Psilocybin, has disrupted our view of the neuroscience and treatment of mood disorders. Our focus is research into the basic science of how these drugs work.  

For inquiries contact Josh Siegel.